We assign a technical rating of 1 out of 10 to PIRS. PIRS scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
When comparing the yearly performance of all stocks, PIRS is a bad performer in the overall market: 73% of all stocks are doing better.
In the last month PIRS has a been trading in the 13.26 - 17.36 range, which is quite wide. It is currently trading near the lows of this range.
Prices have been falling strongly lately, it is better to avoid new long positions here.
Volume is considerably higher in the last couple of days. In combination with the strong move down this is a bad signal.
Warning: PIRS has an average volume of 23124 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
Both the short term and long term trends are neutral. So this is not the most entertaining stock around.
PIRS is an average performer in the Biotechnology industry, it outperforms 69% of 563 stocks in the same industry.
PIRS is currently trading in the middle of its 52 week range. This is in line with the S&P500 Index, which is also trading in the middle of its range.